Meridian Bioscience (VIVO) Misses Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 1.61 +0.01 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.60 | 52 Week High | $21.49 | |||
| Open | $1.62 | 52 Week Low | $15.75 | |||
| Day High | $1.68 | P/E | 1.83 | |||
| Day Low | $1.51 | EPS | $0.88 | |||
| Volume | 694,647 | |||||
